Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000946644-15-000010
Filing Date
2015-03-20
Accepted
2015-03-20 10:17:42
Documents
6
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A heb12311410ka.htm 10-K/A 52115
2 EXHIBIT 23.1 exhibit231-20141.htm EX-23.1 3869
3 EXHIBIT 31.1 exhibit311-20141.htm EX-31.1 4263
4 EXHIBIT 31.2 exhibit312-20141.htm EX-31.2 3690
5 EXHIBIT 32.1 exhibit321-20141.htm EX-32.1 4918
6 EXHIBIT 32.2 exhibit322-20141.htm EX-32.2 4472
  Complete submission text file 0000946644-15-000010.txt   74401
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-27072 | Film No.: 15714975
SIC: 2836 Biological Products, (No Diagnostic Substances)